Ginkaus laboratorija - Company finances
|
EUR
|
2021
From: 2021-02-05
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 15,694 | 64,793 | 83,100 | 125,169 | 81,944 |
| Profit before tax | 8,591 | 14,069 | 1,596 | 23,964 | -3,181 |
| Net profit | 8,591 | 13,364 | 1,516 | 22,766 | -3,181 |
| Equity | 8,691 | 22,055 | 23,571 | 13,337 | 10,156 |
| Liabilities | - | 3,024 | 1,529 | 2,016 | 1,286 |
| Non-current assets | 4,980 | 11,062 | 8,469 | 6,934 | 5,467 |
| Current assets | 4,261 | 14,017 | 16,631 | 8,419 | 5,975 |
| Total assets | 9,241 | 25,079 | 25,100 | 15,353 | 11,442 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 819 | 80 | 1,242 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +312.9% | +28.3% | +50.6% | -34.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 93.0% | 53.3% | 6.0% | 148.3% | -27.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.8% | 60.6% | 6.4% | 170.7% | -31.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 54.7% | 20.6% | 1.8% | 18.2% | -3.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 54.7% | 21.7% | 1.9% | 19.1% | -3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 0.1 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ginkaus laboratorija - Social security debts
The amount of overdue SODRA debt for the company Ginkaus laboratorija as of the last working day is: 161 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 160.96 |
| 2026-09-01 | 2026-09-02 | 160.96 |
| 2026-08-26 | 2026-08-31 | 80.48 |
| 2026-08-23 | 2026-08-23 | 80.48 |
| 2026-08-19 | 2026-08-19 | 80.48 |
| 2026-08-16 | 2026-08-17 | 80.48 |
| 2026-08-01 | 2026-08-14 | 80.48 |
| 2026-07-01 | 2026-07-31 | 241.44 |
| 2026-06-02 | 2026-06-30 | 160.96 |
| 2026-05-03 | 2026-06-01 | 80.48 |
| 2026-04-01 | 2026-04-30 | 241.44 |
| 2026-03-03 | 2026-03-31 | 160.96 |
| 2026-02-03 | 2026-03-02 | 80.48 |
| 2026-01-01 | 2026-01-31 | 217.35 |
| 2025-12-02 | 2025-12-31 | 144.90 |
| 2025-11-01 | 2025-12-01 | 72.45 |
| 2025-10-01 | 2025-10-31 | 217.35 |
| 2025-09-02 | 2025-09-30 | 144.90 |
| 2025-08-01 | 2025-09-01 | 72.45 |
| 2025-07-01 | 2025-07-31 | 217.35 |
| 2025-06-03 | 2025-06-30 | 144.90 |
| 2025-05-04 | 2025-06-02 | 72.45 |
| 2025-04-01 | 2025-04-30 | 217.35 |
| 2025-03-04 | 2025-03-31 | 144.90 |
| 2025-03-03 | 2025-03-03 | 72.45 |
| 2025-03-01 | 2025-03-02 | 144.90 |
| 2025-02-01 | 2025-02-28 | 72.45 |
| 2025-01-02 | 2025-01-31 | 258.00 |
| 2024-12-03 | 2024-12-31 | 193.50 |
| 2024-11-04 | 2024-12-02 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
| 2024-09-03 | 2024-09-30 | 129.00 |
| 2024-08-01 | 2024-09-02 | 64.50 |
| 2024-07-02 | 2024-07-31 | 258.00 |
| 2024-06-03 | 2024-07-01 | 193.50 |
| 2024-05-02 | 2024-06-02 | 129.00 |
| 2024-04-03 | 2024-05-01 | 64.50 |
| 2024-03-01 | 2024-03-31 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-31 | 234.52 |
| 2023-12-01 | 2024-01-02 | 175.89 |
| 2023-11-03 | 2023-11-30 | 117.26 |
| 2023-10-03 | 2023-11-02 | 58.63 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
| 2023-07-03 | 2023-07-31 | 234.52 |
| 2023-06-01 | 2023-07-02 | 175.89 |
| 2023-05-04 | 2023-05-31 | 117.26 |
| 2023-05-02 | 2023-05-03 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-03-01 | 2023-03-31 | 168.21 |
| 2023-02-01 | 2023-02-28 | 109.58 |
| 2023-01-03 | 2023-01-31 | 50.95 |
| 2022-12-01 | 2022-12-31 | 152.85 |
| 2022-11-03 | 2022-11-30 | 101.90 |
| 2022-10-03 | 2022-11-02 | 50.95 |
| 2022-09-01 | 2022-09-30 | 152.85 |
| 2022-08-02 | 2022-08-31 | 101.90 |
| 2022-07-01 | 2022-08-01 | 50.95 |
Ginkaus laboratorija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ginkaus laboratorija, MB (code 305694713) is a small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, revenue declined to €81.9K from €125.2K in 2024 and €83.1K in 2023, showing a weaker top-line trend after the peak reached in 2024. The company posted a net loss of €3.2K in 2025, compared with net profit of €22.8K in 2024 and €1.5K in 2023. The profit margin therefore moved to -3.9% in 2025, after 18.2% in 2024 and 1.8% in 2023. At year-end 2025, total assets stood at €11.4K, down from €15.4K in 2024 and €25.1K in 2023. Equity was €10.2K and liabilities €1.3K, indicating a strong equity base relative to debt. Key ratios for 2025 show ROE of -31.3%, ROA of -27.8%, debt-to-equity of 0.13, and asset turnover of 7.16x. Long-term assets were €5.5K and short-term assets €6.0K.